Enliven Therapeutics
ELVN
#4340
Rank
A$3.69 B
Marketcap
A$61.87
Share price
-0.36%
Change (1 day)
119.16%
Change (1 year)

Market capitalization of Enliven Therapeutics (ELVN)

Market cap: A$3.69 Billion

As of April 2026 Enliven Therapeutics has a market cap of A$3.69 Billion. This makes Enliven Therapeutics the world's 4340th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Enliven Therapeutics from 2023 to 2026

End of year Market Cap

Year Marketcap Change
2026A$3.69 B156.19%
2025A$1.44 B-17.81%
2024A$1.75 B109.89%
2023A$0.83 B

End of Day market cap according to different sources

On Apr 22nd, 2026 the market cap of Enliven Therapeutics was reported to be:

A$3.78 Billion
by Nasdaq info icon info icon
A$3.71 Billion
by CompaniesMarketCap info icon info icon